DOJOLVI Trademark

Trademark Overview


On Friday, March 22, 2019, a trademark application was filed for DOJOLVI with the United States Patent and Trademark Office. The USPTO has given the DOJOLVI trademark a serial number of 88352451. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The DOJOLVI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
dojolvi

General Information


Serial Number88352451
Word MarkDOJOLVI
Filing DateFriday, March 22, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6176000
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements


Goods and Servicespharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 10, 2019
Primary Code005
First Use Anywhere DateTuesday, July 21, 2020
First Use In Commerce DateTuesday, July 21, 2020

Trademark Owner History


Party NameUltragenyx Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events


Event DateEvent Description
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, September 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 10, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 9, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 25, 2020USE AMENDMENT FILED
Wednesday, September 9, 2020EXTENSION 2 GRANTED
Tuesday, August 25, 2020EXTENSION 2 FILED
Tuesday, September 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 25, 2020TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 20, 2019EXTENSION 1 GRANTED
Friday, December 20, 2019EXTENSION 1 FILED
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 29, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, August 27, 2019ASSIGNED TO PETITION STAFF
Wednesday, August 14, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2019ASSIGNED TO EXAMINER
Wednesday, April 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 26, 2019NEW APPLICATION ENTERED IN TRAM